Biogen (BIIB) Exchange Rate Effect (2009 - 2026)
Biogen (BIIB) posted Exchange Rate Effect of -$3.4 million for Q2 2026, up 81.11% on a QoQ basis from -$18.0 million in Q1 2026, and down 104.98% year-over-year from $68.3 million in Q2 2025.
Analysis
Biogen (BIIB) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Biogen has reported Exchange Rate Effect for 18 years, with the latest figure at -$3.4 million in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 104.98% year-over-year to -$3.4 million in Q2 2026; TTM through Jun 2026 was -$22.1 million, a 131.3% decrease from a year earlier, with the FY2025 full-year figure at $101.9 million, up 250.52% from the prior year.
- Exchange Rate Effect was -$3.4 million for Q2 2026 at Biogen, up from -$18.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $68.3 million in Q2 2025, with the low at -$74.4 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is -$433333.3, with a median of -$3.8 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect sank 525.0% in 2022, then jumped 642.06% in 2025.
- Over 5 years, Exchange Rate Effect stood at $67.2 million in 2022, then declined by 28.72% to $47.9 million in 2023, then sank by 255.32% to -$74.4 million in 2024, then soared by 103.36% to $2.5 million in 2025, then tumbled by 236.0% to -$3.4 million in 2026.
- The last three Exchange Rate Effect figures came in at -$3.4 million (Q2 2026), -$18.0 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn | -287,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.40 Mn |
| Mar 31, 2026 | -18.00 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | -3.20 Mn |
| Jun 30, 2025 | 68.30 Mn |
| Mar 31, 2025 | 34.30 Mn |
| Dec 31, 2024 | -74.40 Mn |
| Sep 30, 2024 | 42.40 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -23.10 Mn |
| Dec 31, 2023 | 47.90 Mn |
| Sep 30, 2023 | -28.70 Mn |
| Jun 30, 2023 | -4.10 Mn |
| Mar 31, 2023 | 20.00 Mn |
| Dec 31, 2022 | 67.20 Mn |
| Sep 30, 2022 | -52.30 Mn |
| Jun 30, 2022 | -61.20 Mn |
| Mar 31, 2022 | -9.40 Mn |
| Dec 31, 2021 | -15.80 Mn |
| Sep 30, 2021 | -25.40 Mn |